Home > News > Nanobac Pharmaceuticals, Inc. Announces Confirming Results
February 23rd, 2004
Nanobac Pharmaceuticals, Inc. Announces Confirming Results
Nanobac Pharmaceuticals, Inc. is pleased to announce the publication of independent research which confirms and validates Dr.'s Kajander and Ciftcioglu's findings of the living organism, Nanobacteria Sanguineum, as a causal agent in the formation of kidney stones.
Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014
Guo Lab Shows Potential of RNA as Heat-resistant Polymer Material for Nanoarchitectures April 23rd, 2014
National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014